| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |